Clinical trial
Possible Role of Chloroquine in Conjunction to Prednisone to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
NCT02463331 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Possible Role of Chloroquine in Conjunction to Prednisone to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- July 31, 2016
- Enrollment
- 57 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune hepatitis